Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.9000
+0.2000
+(28.57%)
At close: 3:09:43 PM GMT+1
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Ulla Hald Buhl | COO & Board Member | -- | -- | 1964 |
| Mr. Claus Frisenberg Pedersen | Chief Commercial Officer & Board Member | -- | -- | 1972 |
| Mr. Gerton Jonsson | Chief Financial Officer | -- | -- | 1971 |
CHOSA Oncology AB
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Chosa Oncology AB develops oncology drugs for the treatment of cancer. The company was formerly known as Chosa ApS. Chosa Oncology AB incorporated in 2022 and is based in Lund, Sweden.
Corporate Governance
CHOSA Oncology AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
MAGLE.ST Magle Chemoswed Holding AB (publ)
32.40
0.00%
NV3P.F NanoViricides, Inc.
1.1300
-11.72%
MOC.WA Molecure S.A.
9.00
+1.69%
RGO.DU Regeneron Pharmaceuticals Inc
684.00
+1.33%
HQ1.MU Oruka Therapeutics Inc. R
10.30
-2.83%
BSSP Baseline Productions, Inc.
0.0001
0.00%
PH4.F CStone Pharmaceuticals
0.4320
+1.89%
GYX.F Futura Medical plc
0.1340
-25.56%
BXPHF Botanix Pharmaceuticals Limited
0.2950
0.00%
10VA.F Immunic, Inc.
1.1000
-1.79%